August 29, 2016 9:27 PM ET

Biotechnology

Company Overview of Cerimon Pharmaceuticals, Inc.

Executive Profile

Vaughn M. Kailian

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 16 different industries.

See Board Relationships
71--

Background

Mr. Vaughn M. Kailian serves as Director at Xanodyne Pharmaceuticals, Inc. Mr. Kailian serves as Director at Biotechnology Innovation Organization. He serves as Director at BIO Ventures for Global Health. He serves as Chairman at Cerimon Pharmaceuticals, Inc. He serves as Director, Member of Corporate Governance & Nominating Committee and Member of Stock Option & Compensation Committee at Cephalon, Inc. He serves as Chairman of the Board, Chairman of Audit Committee ...

Corporate Headquarters

701 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-827-4000
Fax: 650-827-4040

Board Members Memberships

Director
Chairman of the Board, Chairman of Audit Committee and Chairman of Nominating & Corporate Governance Committee
Director
Chairman
2005-Present
Director, Member of Corporate Governance & Nominating Committee and Member of Stock Option & Compensation Committee
2009-Present
Director

Education

BA
Tufts University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cerimon Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.